PerkinElmer Inc (PKI)

NYSE
183.84
+1.61(+0.88%)
After Hours
183.90
+0.06(+0.03%)
- Real-time Data
  • Volume:
    1,278,490
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    181.37 - 185.68

PKI Overview

Prev. Close
183.84
Day's Range
181.37-185.68
Revenue
4.85B
Open
183.36
52 wk Range
111.45-185.11
EPS
10.51
Volume
1,278,490
Market Cap
20.61B
Dividend (Yield)
0.28
(0.15%)
Average Vol. (3m)
812,439
P/E Ratio
17.48
Beta
1.1
1-Year Change
54.6%
Shares Outstanding
112,091,175
Next Earnings Date
Nov 03, 2021
What is your sentiment on PerkinElmer Inc?
or
Market is currently closed. Voting is open during market hours.

PerkinElmer Inc News

PerkinElmer Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong BuyStrong BuyStrong BuyStrong Buy
SummarySellStrong BuyStrong BuyStrong BuyStrong Buy

PerkinElmer Inc Company Profile

PerkinElmer Inc Company Profile

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Read More
  • 97.50
    3
    • I thnk It will go up
      1
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.